Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rap guanine nucleotide exchange factor 3 (RAPGEF3), also known as EPAC1, is a cytosolic enzyme that acts as a guanine nucleotide exchange factor specifically for the small GTPases Rap1 and Rap2, becoming activated by direct binding of cyclic adenosine monophosphate (cAMP). RAPGEF3 functions as a major cAMP sensor in human cells, mediating cAMP-induced, protein kinase A-independent signaling pathways. It plays critical roles in regulating actin cytoskeletal dynamics, endothelial barrier function, cellular adhesion, proliferation, stress responses, and other processes. RAPGEF3 is implicated in various pathological states, including cardiovascular disease, cancer, and neuroinflammation, and is considered a potential therapeutic target for related conditions. Small molecules that selectively modulate EPAC1 activity are being investigated for therapeutic intervention.
Direct modulation of intracellular cAMP signaling by allosterically activating or inhibiting RAPGEF3, leading to downstream regulation of Rap GTPase activity and integrin/cytoskeletal effects
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rap guanine nucleotide exchange factor 3 (RAPGEF3).